Literature DB >> 16685004

Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.

Jung-Soo Kim1, Kosuke Okamoto, Bruce K Rubin.   

Abstract

BACKGROUND: Polymorphonuclear neutrophil (PMN)-dominated inflammation is prominent in the airways of subjects with cystic fibrosis (CF) and chronic bronchitis (CB). Interleukin (IL)-8, myeloperoxidase (MPO), and DNA are markers of neutrophilic inflammation. We hypothesized that sputum MPO, DNA, and IL-8 concentrations would negatively correlate with pulmonary function and sputum transportability.
METHODS: We measured pulmonary function and analyzed sputum IL-8, MPO, and DNA concentrations, as well as the transport properties of sputum samples obtained from 16 subjects with CF and 15 subjects with CB. We also evaluated changes in these measurements in paired sputum samples from these subjects obtained 2 to 12 months apart.
RESULTS: IL-8 and MPO concentrations in the sputum of CF subjects was inversely correlated with FEV(1) percent predicted (IL-8: r = -0.40; p = 0.003; MPO: r = -0.38; p = 0.003) and FVC percent predicted (IL-8: r = -0.4; p = 0.02; MPO: r = -0.4; p = 0.02). IL-8 and DNA concentrations were inversely correlated with sputum cough transportability (CTR) [IL-8: r = -0.4; p = 0.02; DNA: r = -0.36; p = 0.048]. Changes in DNA concentration in sputum samples from CF subjects over time were inversely correlated with changes in FEV(1) percent predicted (r = -0.58; p = 0.02), FVC percent predicted (r = -0.74; p = 0.002), and CTR (r = -0.59; p = 0.02). There was no correlation among pulmonary function, sputum properties, and inflammatory markers in the sputum from subjects with CB.
CONCLUSIONS: The sputum concentrations of IL-8, MPO, and DNA appear to be closely associated with pulmonary function in subjects with CF but not in subjects with CB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685004     DOI: 10.1378/chest.129.5.1148

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

Review 1.  Advancing outcome measures for the new era of drug development in cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Bonnie W Ramsey; Richard A Kronmal
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

2.  The role of mucus in cough research.

Authors:  Bruce K Rubin
Journal:  Lung       Date:  2010-01       Impact factor: 2.584

Review 3.  Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.

Authors:  Maaike Cockx; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

4.  Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis.

Authors:  Ruchi Yadav; Dae-Goon Yoo; J Michelle Kahlenberg; S Louis Bridges; Oluwadamilola Oni; Hanwen Huang; Arlene Stecenko; Balázs Rada
Journal:  J Cyst Fibros       Date:  2019-01-10       Impact factor: 5.482

5.  Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.

Authors:  Vihas T Vasu; Sharon J de Cruz; Jessica S Houghton; Keri A Hayakawa; Brian M Morrissey; Carroll E Cross; Jason P Eiserich
Journal:  Free Radic Res       Date:  2010-10-18

6.  Association between pulmonary function and sputum biomarkers in cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Moira L Aitken; Frank J Accurso; Richard A Kronmal; Michael W Konstan; Jane L Burns; Scott D Sagel; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2007-01-18       Impact factor: 21.405

7.  Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.

Authors:  Scott D Sagel; Brandie D Wagner; Margaret M Anthony; Peggy Emmett; Edith T Zemanick
Journal:  Am J Respir Crit Care Med       Date:  2012-08-16       Impact factor: 21.405

8.  Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.

Authors:  Dae-goon Yoo; Matthew Winn; Lan Pang; Samuel M Moskowitz; Harry L Malech; Thomas L Leto; Balázs Rada
Journal:  J Immunol       Date:  2014-04-16       Impact factor: 5.422

Review 9.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

10.  Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.

Authors:  David J Serisier; Mary P Carroll; Janis K Shute; Simon A Young
Journal:  Respir Res       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.